Olshan's Client Footstar Acquires CPEX Pharma
YAHOO! Finance reported on Olshan’s client, Footstar, Inc's deal to acquire 80.5% of CPEX Pharmaceuticals, Inc., a publicly-traded specialty pharmaceutical company, in a transaction valued at approximately $76.6 million. The transaction is being financed through equity,a $64 million secured term loan and $13 million of bridge financing.
The Olshan team that worked on this transaction included: Corporate: Adam W. Finerman, Kenneth A. Schlesinger, Jason W. Soncini and Camielle N. Green; Tax: Nina Krauthamer.